Bioshell Spółka z Ograniczoną Odpowiedzialnością (KRS 0000977305, NIP 7812036807) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. Bioshell operates in: Manufacture of medical and dental instruments and supplies (PKD 32.50.Z). Industry: Other manufacturing. The company has been listed in the National Court Register since June 15, 2022. Bioshell's most recently reported net revenue was 0 PLN for 2023.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Bioshell
Identity
- Name
- Bioshell Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- June 15, 2022
- Registry status as of
- December 3, 2025
- Latest entry
- August 20, 2024
- Founding act
- 14.06.2022
Articles of association history (3)
- June 14, 2022: 14.06.2022
- June 20, 2022: 1. 20.06.2022 R., REP. A 3042/2022, ZASTĘPCA NOTARIALNY MAŁGORZATA LEONARSKA, ZASTĘPCA NOTARIUSZA SZYMONA POSADZY, KANCELARIA NOTARIALNA W POZNANIU PRZY UL. OPALENICKIEJ 66/8, ZMIANA UMOWY SPÓŁKI POPRZEZ NADANIE JEJ NOWEGO BRZMIENIA. 2. 22.08.2022 R., REP. A 4196/2022, NOTARIUSZ SZYMON POSADZY, KANCELARIA NOTARIALNA W POZNANIU PRZY UL. OPALENICKIEJ 66/8, ZMIANA UMOWY SPÓŁKI POPRZEZ NADANIE JEJ NOWEGO BRZMIENIA. 3. 05.12.2022 R., REP. A 5857/2022, ZASTĘPCA NOTARIALNY MAŁGORZATA LEONARSKA, ZASTĘPCA NOTARIUSZA SZYMONA POSADZY KANCELARIA NOTARIALNA W POZNANIU PRZY UL. OPALENICKIEJ 66/8, ZMIANA UMOWY SPÓŁKI POPRZEZ NADANIE JEJ NOWEGO BRZMIENIA.
- June 21, 2024: 21.06.2024 R., REP. A NR 3139/2024, NOTARIUSZ SZYMON POSADZY, KANCELARIA NOTARIALNA W POZNANIU, UL. OPALENICKA 66/8. W UMOWIE SPÓŁKI: ZMIENIONO: § 6 UST. 1, DODANO § 7 UST. 3, PRZYJĘTO TEKST JEDNOLITY UMOWY SPÓŁKI
Activities
Other activities
Address and contact
- Address
- UL. JANA HENRYKA DĄBROWSKIEGO, 77A, 60-529, POZNAŃ, POLSKA
- Voivodeship
- WIELKOPOLSKIE
- District
- POZNAŃ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.4079, 16.9335approx.
Risk and payment profile - Bioshell
Credibility rating
41.6 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
36
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany właścicieli. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
2
2/4 yrs
Board changes
0
0/4 yrs
PKD changes
0
0/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Bioshell
Founded
June 15, 2022
4 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
32.50.Z
Manufacture of medical and dental instruments and supplies
Share capital
6.2 K PLN
122 shares total
Shareholders
3
shareholders
Board
1 person
Filed years
1 year
2023 · profitable: 0/1
Registry entries
11
latest: August 20, 2024
Risk signals
Revenue
0 PLN
2023
Net profit
-226.1 K PLN
2023
Assets
1.3 M PLN
2023
Equity
N/A
2023
EBITDA
-222.4 K PLN
2023
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Bioshell.
No ratings
Related articles
News
Mennica Polska 2026: Q1 revenue up 80% YoY (PLN 726.7m), 838 kg of investment gold, Bulwary Praskie 95% sold, PLN 1.50 dividend
Warsaw-based Mennica Polska S.A. (KRS 0000019196), the only Polish producer of investment-gold bars, with three independent business legs (minting, the City Card transit-ticketing business, and the Bulwary Praskie development), posted Q1 2026 revenue of PLN 726.7m (+80% YoY versus PLN 402.9m) and EBITDA of PLN 56.4m (+28%). Investment-gold sales: 838 kg (+38% by weight YoY). 2025 closed with revenue of around PLN 1.83bn (+31%), EBITDA of around PLN 160m (+29%), and net profit of around PLN 500m (a significant part from the development segment). Bulwary Praskie: 747 apartments with occupancy permits, 95% sold or reserved. Recommended dividend: PLN 1.50 per share (PLN 76.5m).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by a gradual normalisation. Listed on the WSE since 2013, with a three-member management board and a five-member supervisory board.
